Iron deficiency is prevalent in infants and young children in developing countries and is associated with adverse developmental outcomes. The routine provision of additional iron by food fortification or the use of iron supplements is generally recommended. The wisdom of this approach in regions where the transmission of Plasmodium falciparum malaria is perennial and intense is now being questioned, because a large trial in Pemba, Tanzania, demonstrated an increased risk of serious morbidity among children under the age of 3 years who were given routine daily iron and folic acid supplements. However, the results of a concurrent substudy suggest that the untoward effects occurred in children who were not iron deficient, and that iron deficiency itself is associated with an increased risk of severe morbidity that can be reduced by iron and folic acid supplementation. There is an urgent need for additional research to confirm these observations, to establish the role, if any, of the concurrent folic acid supplementation, to evaluate the risk of alternative methods for delivering iron that, on theoretical grounds, could be safer, and to establish the programmatic feasibility of targeting iron fortificants or supplements to iron-deficient children. It is evident that a single strategy for ensuring adequate iron nutrition in young children in different parts of the world is no longer likely to be satisfactory. Moreover, integration with other health-related strategies, particularly malaria control programs, will be essential.
Introduction
Revisions to the current International Nutritional Anemia Consultative Group/World Health Organization/United Nations Children's Fund (INACG/WHO/ UNICEF) Guidelines for the use of iron supplements to prevent and treat iron-deficiency anemia [1] are being considered as the result of inferences drawn from the recent routine prophylactic iron and folic acid supplementation trial conducted among children under the age of 3 years in Pemba, Tanzania. The investigators concluded that "Routine supplementation with iron and folic acid in preschool children in a population with high rates of malaria can result in an increased risk of severe illness and death. " [2] . We will discuss several unanswered questions raised by these findings and outline a few possible strategies for improving iron status without incurring the risk of increased morbidity from malaria and other infections. Our intention is only to raise awareness of some specific issues that we believe may merit further consideration and to provide an initial framework for the discussion of possible intervention strategies. We do not mean to imply that any one strategy deserves greater consideration than the rest or that programmatic implementation is necessarily feasible.
Before describing possible strategies, it would seem logical to try to answer the following questions: » What is the optimal iron status for children exposed to high transmission rates of malaria? » How can available iron indicators be used to define "optimal iron status" and identify children most likely to benefit from an intervention in these environments? » Does the method of iron delivery have an important effect on the benefits and risks of intervention strategies?
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Optimal iron status
Iron balance is rigorously controlled in healthy human beings by the regulation of absorption. Short-term variations in requirements are met by increasing or reducing the rate of release from a true store that appears to have no function other than to enable close matching of supply to demand. In the absence of disorders of iron metabolism and inflammatory diseases, absorption is regulated primarily by the size of the stores and the rate of erythropoiesis [3, 4] . Stores vary from about 10 to 110 mg in healthy 1-to 5-year-old children living in the United States and Canada [5] . Older men have the highest iron stores (the 95th percentile for serum ferritin in men over the age of 70 years is 380 µg/L, which is indicative of a store of approximately 1,400 mg [5, 6] ). However, the definition of optimal iron status remains controversial.
Optimal iron status in regions where the prevalence of malaria and other infections is low
Iron deficiency in infants and young children has several unfavorable consequences. Developmental delays, negative consequences for behavior, long-term effects on auditory and visual function, and less satisfactory scholastic performance when the children are older have all been reported [7] [8] [9] [10] . Iron deficiency leads to impaired physical performance at all ages [11] [12] [13] [14] [15] [16] .
Other important associations include a suboptimal response to iodine prophylaxis in regions where goiter is endemic [17] and increased lead levels in children [18, 19] . The severity and timing of iron depletion necessary to trigger these adverse effects is uncertain. For example, in most studies, the developmental consequences in childhood appear only to be associated with iron deficiency of a degree sufficient to cause anemia, whereas physical performance may improve after iron supplementation in the absence of anemia.
Uncertainty about optimal iron status is equally controversial at the other end of the spectrum. The most important concern is that the likelihood of ironinduced free radical damage may rise as iron stores increase, predisposing the individual to vascular disease and/or cancer. Some investigators have postulated the existence of a causal relationship between high serum ferritin concentrations and the risk of acute myocardial infarction [20] and carotid vascular disease [21] . Furthermore, an increased risk of diabetes mellitus was associated with elevated serum ferritin concentrations in a cross-sectional study of adults in the United States [22] . On the other hand, several prospective cohort studies failed to demonstrate a significant relationship between serum ferritin and a higher risk of coronary heart disease. After carefully reviewing the published evidence, the Institute of Medicine Panel on Micronutrients concluded that there was insufficient evidence to support a causal relationship between high body iron stores and the risk of coronary heart disease [5] . Hepatocellular carcinoma is a well-established consequence of severe phenotypically expressed HFE hemochromatosis. It results from accumulation of iron in the liver with consequent cirrhosis. However, evidence for a relationship between iron intake or iron status and cancer in the general population is inconclusive [5] .
In summary, it appears that considerable variation in iron storage status is characteristic of normal health in countries where the prevalence of malaria and other serious chronic infections is low. The effects of iron deficiency only occur when iron stores are exhausted, although functional consequences may appear before there is a measurable limitation to the production of hemoglobin. A large store of body iron is not known to confer any functional advantage, other than the ability to respond rapidly to changes in physiological requirements and to supply the early demands of pregnancy. Pathological consequences occur only when the size of the store approaches 3 to 5 g in adults.
The Institute of Medicine Panel on Micronutrients calculated the estimated average dietary iron requirement for all ages (excluding pregnant women) based on the need to maintain functional iron adequacy but only a minimal iron store. Serum ferritin concentration was used as the indicator for this threshold level and was set at 15 µg/L (indicative of a store of 100 to 200 mg of iron in an adult) [5] . It is noteworthy that very little attention was paid to the relationship between iron status and infection in these analyses.
Optimal status in regions with a high prevalence of malaria and other infections
Iron deficiency is associated with several specific defects in cell-mediated immunity [23] , although their influence on overall health appears to be minor when compared with clinically defined immunodeficiency syndromes [24] . Its impact on humoral immunity is even less. The third component of iron-related immunity, the ability of body tissues and fluids to limit the access of pathogens to iron, may have a significant role [25] . Kochan first proposed the term "nutritional immunity" for immunity based on mechanisms that limit the acquisition of trace elements by pathogens [26] . Although there is persuasive evidence for the importance of "nutritional immunity" at the cellular level, body iron status does not appear to have a major effect on the course of most infectious diseases. Infection is a rare cause of serious morbidity or death in patients with severe iron overload due to HFE hemochromatosis, although there are a few reports of illnesses caused by pathogens such as Pasteurella pseudotuberculosis, Yersinia enterocolitica, and Vibrio vulnificus [27, 28] . It is postulated that the presence of non-transferrin-bound iron in the plasma of patients with hemochromatosis increases the virulence of these organisms, which lack the capacity to acquire iron readily from host tissues [28] . Infections are common in patients with sickle cell anemia but occur most often in the first decade of life, before the accumulation of excessive body iron [29] . Severe bacterial infections are an important cause of morbidity and mortality in thalassemia major, but other factors, such as splenectomy and severe anemia, may have a more important role than iron overload [29] . The nature of the relationship between excessive body iron and the course of tuberculosis in patients with sub-Saharan dietary iron overload is also uncertain because of associated confounding factors [30] .
Iron status could have a more critical role in developing countries, where malaria and other serious infections are endemic and still the leading cause of death [31] . The "nutritional immunity" hypothesis has been extended to imply that protective properties of ironbinding proteins such as transferrin and lactoferrin could be enhanced by systemic iron deficiency. Observational studies in human subjects that are based on an assessment of iron status and not on the interpretation of the results of iron administration would provide the most convincing evidence for or against beneficial effects of iron deficiency. However, it is very difficult to establish causality from the few surveys that have been done because of the numerous confounding factors and the unreliability of iron status indicators in the presence of inflammation. Studies based on hemoglobin alone may be misleading, since other causes of anemia are common in these populations. Furthermore, carrier states of thalassemia and some hemoglobinopathies are prevalent in many tropical regions. They both cause mild anemia and are protective against severe clinical malaria in young children.
Snow et al. found no correlation between iron status at the beginning of the malaria transmission season and morbidity from malaria in 1-to 9-year-old Gambian children [32] . The most comprehensive recent analyses of the relationships between iron status and malaria were carried out by Nyakeriga et al. [33] [34] [35] . Their observations raise several important questions that are beyond the scope of this report. They did, however, draw three relevant conclusions [33] . There were no differences in parasite densities during incident malarial infections between iron-deficient and iron-replete children. There was no association between iron deficiency and the incidence of nonmalarial fever or morbidity from all diseases, including malaria. However, iron deficiency did appear to have a small protective effect, but only against attacks of mild clinical malaria. On the other hand, the risk of severe malaria-related morbidity was increased in iron-deficient children in the placebo group in the Pemba substudy (discussed below).
We conclude that there is currently very little evidence to support the suggestion that "nutritional immunity" can be enhanced by inducing systemic iron deficiency or that this would have a beneficial effect on the clinical outcome of malarial infections.
In summary, the current evidence suggests that it would be prudent to attempt to assure adequate functional iron status in young children, even in regions where malarial transmission is intense. Strategies designed to target children who would benefit from an iron intervention because of their suboptimal iron status depend on the appropriate use of the best indicators.
Iron status indicators
Finch first proposed that iron indicators could be used to recognize three stages of deficiency that would be induced by the gradual depletion of body iron [36] . A modified version of this concept to include some of the indicators that were not available to Finch and his colleagues is outlined in table 1. It is important to note that the events in this model, particularly the sequential series of events that leads from normal iron status to storage iron depletion, then a suboptimal supply of iron to the functional compartment without measurable deficiency, and finally shrinkage of the largest functional compartment, the circulating red cell mass, occurs only when iron deficiency evolves gradually due solely to an imbalance between absorption and the sum of requirements and losses. In many clinical settings, 
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Critical review of strategies other factors alter these relationships. These indicators have been employed singly or in combination in the evaluation of iron status in individuals and populations. Cook et al. [37] showed that a single abnormal indicator had very little predictive value for identifying anemia among residents of the northwestern United States. The predictive value increased sequentially when two and three indicators were abnormal. Multiple indicator models were used extensively in the National Health and Nutrition Examination Surveys (NHANES) of iron status in the United States. It should, however, be noted that the employment of multiple indicators increases specificity for recognizing iron-deficiency anemia but would be expected to underestimate the overall prevalence of iron deficiency with or without anemia.
A joint WHO/Centers for Disease Control and Prevention (CDC) Technical Consultation recently reevaluated the use of iron indicators for the assessment of iron status and the impact of intervention strategies at the population level [38, 39] . The intention was to make a single set of recommendations that could be applied to both Western and developing countries. Technical limitations to implementation in the field were therefore taken into account, but considerable weight was nevertheless given to the selection of laboratory tests that had a high degree of specificity. Only five indicators were considered: hemoglobin, mean cell volume (MCV), serum ferritin concentration, serum transferrin receptor concentration, and red cell protoporphyrin measured as the zinc protoporphyrin/ hemoglobin ratio (ZPP/H).
The Consultation reached the following conclusions:
Hemoglobin is an insensitive indicator of nutritional iron deficiency, with inadequate specificity, because there are many other causes of anemia. They include vitamin A deficiency, malaria and other infections, thalassemias, and hemoglobinopathies. Furthermore, it is difficult to establish normal ranges for epidemiological studies because of variations related to ethnicity, age, sex, stage of pregnancy, altitude, and smoking habits. Anemia does, however, have important functional and public health consequences and can be used to provide information about severity when iron deficiency has been established and to evaluate the response to an intervention. Accurate field methods for measuring hemoglobin are available, but reliable results require appropriate training and monitoring of operator performance.
Mean cell volume is a useful indicator of iron deficiency if thalassemia and inflammation can be excluded. Accurate results require access to expensive equipment.
Serum ferritin concentration is a precise, semiquantitative measure of iron storage status in otherwise healthy individuals. However, serum ferritin levels are increased in infectious and inflammatory disorders, making it difficult to set universally applicable threshold levels for establishing the prevalence of iron deficiency in population surveys in many developing countries. WHO/UNICEF/United Nations University (UNU) recommends a threshold value of < 12 to 15 µg/L [40] . The Consultation considered it unlikely that this threshold would be applicable in the presence of infection and suggested the concurrent assay of an acute-phase protein such as C-reactive protein or alpha 1-acid glycoprotein (AGP). Samples with high acutephase protein values could then be excluded. However, the high prevalence of inflammation in many parts of Africa reduces the feasibility of this approach [41] . Attempts to correct serum ferritin concentration for the inflammation effect lack the required precision at the present time [42] .
Many investigators have used considerably higher threshold levels for serum ferritin on an empirical basis. For example, van den Broek demonstrated that serum ferritin was the best single indicator of the presence of bone marrow storage iron in anemic pregnant women in Malawi, provided that a cutoff value of 30 µg/L was used [43] . Although serum ferritin may lack the desired sensitivity in epidemiological studies, values of < 12 to 15 µg/L were highly specific for iron deficiency in Zanzibari children [44] . Furthermore, it may be the best single indicator of a response to an intervention, even in populations with a high prevalence of malaria [45] . Serum ferritin assays can be adapted for field settings, provided that it is possible to separate serum or plasma from the cellular elements of the blood sample within a fairly short period of time [46] .
Serum transferrin receptor concentration reflects the balance between iron supply and total cellular requirements and is a semiquantitative measure of iron deficiency, even in the presence of most infections. Values are, however, affected by the rate of erythropoiesis [41, 47, 48] , which is in turn influenced by hemolysis and malaria. Its usefulness is further limited by the current lack of adequate methodological standardization.
Red cell protoporphyrin measured as the zinc protoporphyrin/hemoglobin ratio (ZPP/H). ZPP is a metabolic intermediate of the hemoglobin synthetic pathway that accumulates in red blood cells when the iron supply is limited because zinc becomes an alternative metal substrate for ferrochetalase in the final step of heme synthesis [49, 50] . This metal substitution is an early manifestation of functional iron deficiency in erythrocyte precursors. ZPP levels are unaltered during the lifespan of the erythrocyte. Assay results therefore reflect the average iron availability to the bone marrow during the preceding 3 months. The confusion related to the use of the terms ZPP and EP (erythrocyte protoporphyrin) or FEP (free erythrocyte protoporphyrin) resulted from analytical procedures in earlier studies that, unbeknown to the investigators, converted ZPP to EP. ZPP is most conveniently expressed as a ratio based on micromoles of ZPP per mole of heme (ZPP/H). The ratio can be measured directly on a drop of blood using a dedicated front-face flurorometer (hematofluorometer) in field studies. An increased red cell ZPP/H ratio is not a specific indicator of iron deficiency. ZPP/H values may also be raised by exposure to lead and in chronic inflammatory diseases and disorders that affect hemoglobin synthesis. Finally, fluorescent compounds, such as bilirubin and various drugs circulating in the plasma, may influence the result unless washed red cells are used (discussed in more detail below).
The WHO/CDC Consultation reviewed the performance of these indicators in 10 double-blind, randomized, controlled iron-supplementation or food-fortification trials considered to be very likely to have had an effect on iron status based on the selected iron compound as well as the dose and duration of the intervention [39] . Serum ferritin and serum transferrin receptor values used in combination were most predictive of the change in iron status, although serum ferritin alone was almost as good. It is important to note that this was an analysis of impact, not initial iron status, and that infections were not prevalent in most of the study groups.
The Consultation made the following recommendations: » Iron-deficiency prevalence cannot be estimated reliably from anemia prevalence alone. There are several other causes of anemia, a number of which may be as prevalent as iron deficiency in some populations. However, hemoglobin should be measured routinely because it is an important health indicator. It also provides information about the severity of iron deficiency. » The combined measurement of serum ferritin and transferrin receptor concentrations to calculate body iron status [51] is the most sensitive and specific approach and may permit predictions to be made from relatively small sample sizes. The method has three additional significant advantages. It has been calibrated against measured iron status calculated by serial phlebotomy in adults, can be used to characterize a wide range of iron statuses varying from iron deficiency to high iron stores, and does not depend on establishing threshold levels. A recommendation was made to use this method for characterizing iron status in future NHANES surveys at a subsequent CDC workshop (March 2005). The Consultation did, however, recognize that there are several obstacles to using this approach in populations where infectious diseases are prevalent. In summary, there is at the present time no convincing evidence to indicate that iron deficiency provides significant protection against morbidity or mortality from malaria or other infections. Public health measures should be designed to ensure optimal functional iron status because of the other putative benefits of iron sufficiency in children, even in regions where malaria and other infections are prevalent. If iron status screening is used to identify target groups for ironintervention strategies, it would be best to choose one or more indicators that reflect the size of iron stores or identify early functional iron deficiency. The indicators selected for characterizing iron status in Western populations-serum ferritin and transferrin receptorare unlikely be the most suitable for the assessment of children in malarial regions at the present time. More research is needed to establish their potential utility or identify alternative approaches.
As discussed later, the substudy from the Pemba trial provides encouraging evidence indicating that raised ZPP/H levels can be used to identify children who will have a substantial benefit from iron supplementation because of reduced morbidity related to malaria. Serum ferritin was measured in the Pemba substudy. It would be prudent to review these results before drawing firm conclusions about the lack of utility of this indicator.
Impact on morbidity of iron intake and interventions to reverse iron deficiency Western countries
A considerable range of intakes appears to be safe, provided that sufficient bioavailable iron is consumed to prevent functional iron deficiency. There are only isolated reports of clinically significant iron overload occurring as the result of the consumption of large quantities of iron over an extended period of time in individuals not suffering from an iron-loading disorder [36] . There were no differences in iron storage status as measured by serum ferritin concentrations between adults in the lower and upper quartiles of iron intake in the third US National Health and Nutrition Examination Survey (NHANES III, 1988-1994) [5] . Therefore, the Subcommittee on Upper Levels of Micronutrients of the Institute of Medicine based the upper level for iron intake on a side effect of iron supplementation or treatment that is primarily associated only with discomfort, referred to as "gastrointestinal distress. " They set the level at 40 mg/day for children up to the age of 13 years in the recently published Dietary Reference Intakes [5] .
Oppenheimer [31] analyzed 13 long-term, controlled iron-intervention studies in nonmalarial areas and drew the following conclusions: » Parenteral iron administration at birth carries a significant risk of sepsis and meningitis, but both parenteral and oral iron supplementation given after the neonatal period reduce subsequent morbidity due to respiratory and gastrointestinal infections. » There is a strong case for fortification of milk formulas, with no evidence that this practice increases
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Africa and other regions with a high prevalence of malaria
Iron overload related to high iron consumption is an epidemiologically important problem that is unique to populations in sub-Saharan Africa [36] . It appears to have an important genetic component [52] . This is a disorder that affects adults rather than children and has the highest incidence in men. Iron supplementation could have effects on the competition of pathogens for iron that are at least in part independent of iron status. Hyperferremia is present for several days after the intravenous administration of iron dextran, and for several weeks if it is given by the intramuscular route [31] . The bacteriostatic properties of plasma may be reduced during this period. Oral iron supplements also increase plasma iron concentrations and reduce transferrin saturation for several hours after the iron has been ingested [53] [54] [55] [56] [57] . In either case, some of the iron could exist in the non-transferrin-bound state. Although Oppenheimer [31] suggested that long-term supplementation studies could be used to "separate the early effects of treatment from the effects of steady-state improved iron balance, " it is important to consider the possibility that at least one important iron compartment (the plasma transferrin pool) is repeatedly accommodating an influx of quantities of iron sufficient to change its putative "nutritional immunity" properties during periods of regular ingestion of iron supplements. Other critical compartments could also be affected.
Oppenheimer analyzed 11 controlled trials from malarial regions and reached the following conclusions related to the potential risk of iron supplementation:
There was a significant increase in malarial attacks in five of nine studies, of nonmalarial infections in four of eight, and of pneumonia in two of nine. No study showed protection against these morbidities. Oppenheimer was unable to determine whether the severity of iron deficiency might be an effect modifier. There was weak circumstantial evidence of a dose-related risk. There was no evidence that risk was related to the age of intervention or the duration of therapy in children.
The results of the Pemba study are generally consistent with these earlier observations. The sample size and statistical power allow for a more definitive interpretation. The risk of serious infectious morbidity related to malaria was significantly increased in the children receiving iron and folic acid. There was suggestive evidence of increased mortality. There was no evidence to indicate that the morbidity rate could be modified by age at initiation or duration of the intervention. The morbidity appeared to result from increased clinical severity of malarial episodes and associated infections rather than increased prevalence, which is supported by earlier observations indicating that low-dose iron supplementation to Zanzibari children aged 4 to 71 months does not increase the prevalence of malarial infections or the density of parasites [58] .
The Pemba trial, however, contains an additional set of observations. The investigators conducted a substudy in which they evaluated the relationship between baseline anemia and iron status (characterized by ZPP/H ratio) and the effects of iron and folic acid supplementation on infectious disease morbidity. Children with hemoglobin values of 70 to 100 g/L or ZPP/H ratios of 80 or more had significantly fewer overall adverse events than those with hemoglobin values above 100 g/L or ZPP/H ratios under 80 [2] . The Pemba investigators drew the following conclusion: "In the presence of an active programme to detect and treat malaria and other infections, iron-deficient and anemic children can benefit from supplementation. " Furthermore, iron deficiency (ZPP/H ≥ 80) increased the adverse event rate in the placebo group (9.76 vs. 4.83 adverse events/100 child-years). The most plausible interpretation of these observations is that iron deficiency increases the risk of infection-related serious morbidity in the presence of perennial and intense malarial transmission in children under the age of 3 years, and the risk can be reduced significantly by iron supplementation. However, it is important to note that the experimental design does not permit a potential role for folic acid to be excluded.
In summary, with the exception of parenteral iron administered immediately after birth, iron supplementation is safe in regions where the prevalence of malaria and other infections is low. There is an increased risk of morbidity from malaria and other infections for both parenteral and oral iron supplementation in regions where malaria is prevalent. There is weak circumstantial evidence of greater risk with higher doses. This risk of oral iron supplementation appears to be restricted to children who are not iron deficient or moderately anemic. Paradoxically, the Pemba substudy suggests that iron deficiency increases the risk of severe malariarelated morbidity in children under the age of 3 years and that this risk can be reduced significantly by iron and folic acid supplementation.
Possible strategies to prevent and control iron deficiency in children in regions where malaria and other infections are prevalent

Screening for iron deficiency
The Pemba results provide the most persuasive argument for iron status screening and delivery of supplements only to iron-deficient children in regions of the world where the transmission of falciparum malaria is perennial and intense and children have an 80% chance of being infected in the first year of life [59] . The trial results revealed an overall increase in the risk of severe malaria and associated infection-related morbidity in children receiving iron and folic acid supplements, but a substantial benefit for those who had high ZPP/H ratios or low hemoglobin levels.
Potential screening indicators
Hemoglobin and ZPP/H were the indicators reported in Pemba. Both identified children who benefited from iron and folic acid. Serum ferritin was also measured, but the results have not been reported.
Hemoglobin: There are many reasons for low hemoglobin in children living on the island of Pemba. They include ethnic differences in the normal range of hemoglobin values; high prevalence rates of thalassemias and hemoglobinopathies; infectious diseases, particularly malaria; and nutritional deficiencies of iron, vitamin A, and perhaps riboflavin.
ZPP/H: ZPP/H is a measure of early functional iron deficiency (iron-deficient erythropoiesis [49] ). Levels are increased before there is a measurable fall in hemoglobin [36, 60] . However, the possible role of potential confounding factors needs to be considered.
Increased ZPP/H levels are also encountered in several other settings. Acute lead toxicity may inhibit ferrochetalase, but the more common state of chronic lead toxicity is thought to block intracellular iron transfer, reducing the availability of iron to ferrochetalase. More ZPP is synthesized [61] . ZPP/H is raised in the anemia of inflammation (anemia of chronic disease) because delivery of iron to the bone marrow is restricted. However, the impact of inflammation on ZPP levels is smaller than that of iron deficiency. In one study, ZPP/H was a better indicator of iron deficiency than serum ferritin in the presence of inflammation [62] . ZPP has also been shown to be elevated in betathalassemia trait, alpha-thalassemia trait, hemoglobin E disease, and some sickle cell carriers [63] [64] [65] [66] [67] [68] [69] [70] . Elevated values occur in a greater percentage of individuals with beta-thalassemia trait than in those with alphathalassemia trait. However, levels above 150 µmol/mol of heme are highly suggestive of iron deficiency, even when thalassemia trait is present. Finally, the ZPP/H measurements in Pemba employed whole blood samples. Hastka et al. [71] have demonstrated the ZPP/H levels measured by front-face hematofluorometry are higher in whole blood than when washed red blood cells are used, due to the presence of interfering substances in the plasma. Bilirubin and several drugs, some of which may be administered to children in developing countries, can raise ZPP/H values.
Significance of ZPP/H ratios in the Pemba trial
The positive correlation between ZPP/H and blood lead levels is well described, but ZPP/H does not begin to rise until lead levels exceed 15 µg/dL [72] . Blood lead levels in Pemban children are well below this range. A survey of schoolchildren conducted in 1998 found that less than 3% had blood levels above 15 µg/dL (2 of 75 children; unpublished data from R. J. Stoltzfus, M. Ramsan, and H. M. Chwaya).
Infectious and inflammatory disorders, including malaria, may well have contributed to the increase in ZPP/H levels in the Pemba trial. However, the confounding effect of inflammation appears to be smaller for ZPP/H than for ferritin [62] . Moreover, if this were the case, one might have expected the opposite association-direct correlation between high ZPP/H values and increased serious morbidity.
The possibility that a plasma factor, for example an antibiotic such as tetracycline, could have contributed to both higher ZPP/H levels and a lower risk of serious morbidity deserves further investigation, but we have no information to suggest that this occurred.
The most likely confounding factor might be the association between the alpha-thalassemia or sickle cell disease carrier states and increased ZPP/H levels. Carrier states for alpha-and beta-thalassemias and the structural variant hemoglobins S, C, and E have been reported to provide protection against severe malarial morbidity in children under the age of 5 years. The mechanisms of protection are uncertain [73] [74] [75] . Observations made in Papua New Guinea [76] and Ghana [74] indicate that alpha+-thalassemia also protects children against malaria and other infections. The frequencies of HbS and the -alpha 3.7 allele are estimated to be 10% to 15% and more than 40%, respectively, in the region of East Africa in which Pemba is located [77] . Oppenheimer -20, 2005) suggested that the observed benefit of iron supplementation in children with high ZPP/H levels in the substudy may reflect the selection of individuals who were alpha+-thalassemia or sickle cell carriers. Their risk of severe malarial morbidity would have been lower and they may perhaps have had some protection from the putative adverse effects of iron administration. Oppenheimer's hypothesis would not reduce the value of choosing ZPP/H as the primary screening tool. However, it is unlikely that thalassemia or sickle cell disease carrier status accounts for the apparent beneficial effect of iron supplementation in children with high ZPP/H levels, for two reasons. First, the effect on ZPP/H levels is modest. Second, the morbidity event rate for children in the placebo arm with high ZPP/H levels was increased to approximately twice that of children with S617 Critical review of strategies lower levels (9.76 vs. 4.83 per 100 child-years [2] ). If high ZPP/H were a reflection of thalassemia or sickle cell disease carrier status, a protective effect and a lower event rate would have been anticipated.
Choice of indicator
A case could be made for screening with ZPP/H ratio, hemoglobin, or both. ZPP/H has the theoretical advantage of being unaffected by the capillary sampling technique and requires no manipulation of the sample, but currently available assay instruments may not be sufficiently robust for routine fieldwork. Hemoglobin measurements in the field employing the Hemocue or a similar instrument can yield accurate results. However, careful training and monitoring of the operators to ensure that suitable capillary blood samples are obtained is essential. Although it is probably unlikely that serum ferritin will prove to be a suitable indicator for screening, it would be prudent to analyze the results of the Pemba substudy further before making a definitive decision.
Conclusions
The relative importance of screening on the one hand and an active program to detect and treat malaria on the other is not clear. The results from Pemba suggest that screening may be required to achieve optimal benefit, even if malaria and other infections are being managed effectively. There is little doubt that every effort should be made to integrate iron supplementation with malaria prevention and treatment programs in regions where malaria is prevalent. Coordination with other health-related interventions, particularly programs to control helminth infections such as hookworm, is also highly desirable.
Consideration should be given to individual screening versus setting population prevalence levels for iron deficiency that would ensure maximal benefit with minimal risk.
The current cutoff levels for ZPP/H should be reviewed to determine whether they are optimal for determining the benefit-risk ratio.
Modification of the intervention strategy
Further research into the possibility that risk is related to the method of delivering iron to iron-deficient children with malaria is an urgent research priority. Risk to the more iron-sufficient children might theoretically be reduced by delivery as part of a complementary feeding intervention. Such an approach might reduce the magnitude of the postprandial rise in serum iron concentration because absorption is more gradual. Furthermore, improved protein and energy intake would be expected to raise plasma transferrin levels, reducing the potential for low transferrrin concentrations to permit more non-transferrin-bound iron to circulate. However, interventions employing complementary feeding introduce another set of considerations. Iron requirements are high between 6 and 12 months of age. For complementary foods to be an adequate source of iron, they must be fortified with high levels of bioavailable iron, thereby increasing the cost [78] . There is also a risk of reducing the consumption of breastmilk, which is clearly the much more important factor in the child's overall health and nutrition.
Consideration should also be given to recommendations for complementary food supplements such as "Sprinkles" and "spreads" [79] or intermittent (once a week) dosing [80] . There are theoretical reasons to suggest that complementary food supplements may provide a safer means of delivering iron. However, further research is needed to establish the validity of these assertions.
Elimination of the folic acid supplements
Folic acid deficiency is not known to have an important impact on infection. However, there is no clear evidence to suggest that folic acid deficiency is prevalent in children in most developing countries. In their thoughtful comments on the Pemba trial, English and Snow [59] noted that the antifolate combination of sulfadoxine and pyrimethamine was first-line treatment for malaria at the time of the Pemba trial and that the addition of folic acid supplements to this regimen delays parasite clearance [81, 82] . Although this may be a less likely explanation for the findings in Pemba, it would seem prudent at the present time to remove folic acid from the iron supplements given to children where malarial transmission occurs year-round.
Summary
As a result of the observations made in Pemba, recommendations for strategies to control and prevent iron deficiency in children should be revised. A single strategy for different parts of the world is no longer likely to be satisfactory. Integration with other health-related strategies, particularly malaria control programs, will be essential. It would be prudent to modify the current recommendations immediately on at least a provisional interim basis while recognizing that further research is needed to identify optimal approaches. In making these adjustments and designing further research, consideration should be given to a better understanding of the optimal iron status in various environments and methods for quantifying optimal iron status, as well as strategies for delivering additional iron safely.
